Docosahexaenoic acid suppresses the activity of peroxisome proliferator-activated receptors in a colon tumor cell line

Biochemical and Biophysical Research Communications

Volumn 298, Issue 5, 2002, Pages 667-674

  Lee, Joo Y ^a   Hwang, Daniel H ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

CD36; Colon tumor; Docosahexaenoic acid; Linoleic acid; Peroxisome proliferator activated receptors

Indexed keywords

CD36 ANTIGEN; DOCOSAHEXAENOIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; UNSATURATED FATTY ACID;

ARTICLE; COLON CARCINOMA; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TRANSACTIVATION; TUMOR CELL LINE;

ANTIGENS, CD36; BINDING SITES; COLONIC NEOPLASMS; DIETARY FATS, UNSATURATED; DNA; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, UNSATURATED; GENE EXPRESSION; HUMANS; LINOLEIC ACID; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0036432889     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)02530-5     Document Type: Article

References (46)

1. D. Hwang, Fatty acids and immune responses - A new perspective in searching for clues to mechanism, Annu. Rev. Nutr. 20 (2000) 431-456
2. S.D. Clarke, D. Gasperikova, C. Nelson, A. Lapillonne, W.C. Heird, Fatty acid regulation of gene expression: A genomic explanation for the benefits of the mediterranean diet, Ann. N. Y. Acad. Sci. 967 (2002) 283-298
3. S.D. Clarke, Polyunsaturated fatty acid regulation of gene transcription: A molecular mechanism to improve the metabolic syndrome, J. Nutr. 131 (2001) 1129-1132
4. D.B. Jump, S.D. Clarke, Regulation of gene expression by dietary fat, Annu. Rev. Nutr. 19 (1999) 63-90
5. W.C. Willett, M.J. Stampfer, G.A. Colditz, B.A. Rosner, F.E. Speizer, Relation of meat, fat, fiber intake to the risk of colon cancer in a prospective study among women, N. Engl. J. Med. 323 (1990) 1664-1672
6. C.P. Caygill, M.J. Hill, Fish, n-3 fatty acids and human colorectal and breast cancer mortality, Eur. J. Cancer Prev. 4 (1995) 329-332
7. E. Giovannucci, W.C. Willett, Dietary factors and risk of colon cancer, Ann. Med. 26 (1994) 443-452
8. M.D. Boudreau, K.H. Sohn, S.H. Rhee, S.W. Lee, J.D. Hunt, D.H. Hwang, Suppression of tumor cell growth both in nude mice and in culture by n-3 polyunsaturated fatty acids: Mediation through cyclooxygenase-independent pathways, Cancer Res. 61 (2001) 1386-1391
9. D.J. Mangelsdorf, R.M. Evans, The RXR heterodimers and orphan receptors, Cell 83 (1995) 841-850
10. D.J. Mangelsdorf, C. Thummel, M. Beato, P. Herrlich, G. Schütz, K. Umesono, B. Blumberg, P. Kastner, M. Mark, P. Chambon, R.M. Evans, The nuclear receptor superfamily: The second decade, Cell 83 (1995) 835-839
11. A. Chawla, J.J. Repa, R.M. Evans, D.J. Mangelsdorf, Nuclear receptors and lipid physiology: Opening the X-files, Science 294 (2001) 1866-1870
12. S. Kersten, B. Desvergne, W. Wahli, Roles of PPARs in health and disease, Nature 405 (2000) 421-424
13. C. Juge-Aubry, A. Pernin, T. Favez, A.G. Burger, W. Wahli, C.A. Meier, B. Desvergne, DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region, J. Biol. Chem. 272 (1997) 25252-25259
14. S.A. Kliewer, K. Umesono, D.J. Noonan, R.A. Heyman, R.M. Evans, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature 358 (1992) 771-774
15. I. Issemann, S. Green, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature 347 (1990) 645-650
16. K. Schoonjans, B. Staels, J. Auwerx, The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation, Biochim. Biophys. Acta 1302 (1996) 93-109
17. A. Schmidt, N. Endo, S.J. Rutledge, R. Vogel, D. Shinar, G.A. Rodan, Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids, Mol. Endocrinol. 6 (1992) 1634-1641
18. R.A. Gupta, J. Tan, W.F. Krause, M.W. Geraci, T.M. Willson, S.K. Dey, R.N. DuBois, Prostacyclin-mediated activation of peroxisome proliferator-activated receptor δ in colorectal cancer, Proc. Natl. Acad. Sci. USA 97 (2000) 13275-13280
19. T.C. He, T.A. Chan, B. Vogelstein, K.W. Kinzler, PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs, Cell 99 (1999) 335-345
20. L. Michalik, B. Desvergne, N.S. Tan, S. Basu-Modak, P. Escher, J. Rieusset, J.M. Peters, G. Kaya, F.J. Gonzalez, J. Zakany, D. Metzger, P. Chambon, D. Duboule, W. Wahli, Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR)α and PPARβ mutant mice, J. Cell Biol. 154 (2001) 799-814
21. N.S. Tan, L. Michalik, N. Noy, R. Yasmin, C. Pacot, M. Heim, B. Fluhmann, B. Desvergne, W. Wahli, Critical roles of PPARβ/δ in keratinocyte response to inflammation, Genes Dev. 15 (2001) 3263-3277
22. P. Tontonoz, E. Hu, B.M. Spiegelman, Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor, Cell 79 (1994) 1147-1156
23. E.D. Rosen, B.M. Spiegelman, PPARγ: A nuclear regulator of metabolism, differentiation, cell growth, J. Biol. Chem. 276 (2001) 37731-37734
24. P. Sarraf, E. Mueller, D. Jones, F.J. King, D.J. DeAngelo, J.B. Partridge, S.A. Holden, L.B. Chen, S. Singer, C. Fletcher, B.M. Spiegelman, Differentiation and reversal of malignant changes in colon cancer through PPARγ, Nat. Med. 4 (1998) 1046-1052
25. D. Bishop-Bailey, T. Hla, Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-Δ12, 14-prostaglandin J2, J. Biol. Chem. 274 (1999) 17042-17048
26. G. Chinetti, S. Griglio, M. Antonucci, I.P. Torra, P. Delerive, Z. Majd, J.C. Fruchart, J. Chapman, J. Najib, B. Staels, Activation of proliferator-activated receptors α and γ induces apoptosis of human monocyte-derived macrophages, J. Biol. Chem. 273 (1998) 25573-25580
27. A.M. Lefebvre, I. Chen, P. Desreumaux, J. Najib, J.C. Fruchart, K. Geboes, M. Briggs, R. Heyman, J. Auwerx, Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+mice, Nat. Med. 4 (1998) 1053-1057
28. E. Saez, P. Tontonoz, M.C. Nelson, J.G. Alvarez, U.T. Ming, S.M. Baird, V.A. Thomazy, R.M. Evans, Activators of the nuclear receptor PPARγ enhance colon poly(p) formation, Nat. Med. 4 (1998) 1058-1061
29. B.H. Park, B. Vogelstein, K.W. Kinzler, Genetic disruption of PPARδ decreases the tumorigenicity of human colon cancer cells, Proc. Natl. Acad. Sci. USA 98 (2001) 2598-2603
30. S.A. Kliewer, S.S. Sundseth, S.A. Jones, P.J. Brown, G.B. Wisely, C.S. Koble, P. Devchand, W. Wahli, T.M. Willson, J.M. Lenhard, J.M. Lehmann, Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ, Proc. Natl. Acad. Sci. USA 94 (1997) 4318-4323
31. B.M. Forman, J. Chen, R.M. Evans, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ, Proc. Natl. Acad. Sci. USA 94 (1997) 4312-4317
32. C. Wolfrum, C.M. Borrmann, T. Borchers, F. Spener, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors α- and γ-mediated gene expression via liver fatty acid binding protein: A signaling path to the nucleus, Proc. Natl. Acad. Sci. USA 98 (2001) 2323-2328
33. S.R. Thoennes, P.L. Tate, T.M. Price, M.W. Kilgore, Di+erential transcriptional activation of peroxisome proliferator-activated receptor γ by ω-3 and ω-6 fatty acids in MCF-7 cells, Mol. Cell. Endocrinol. 160 (2000) 67-73
34. J.Y. Lee, K.H. Sohn, S.H. Rhee, D. Hwang, Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclo-oxygenase-2 mediated through Toll-like receptor 4, J. Biol. Chem. 276 (2001) 16683-16689
35. S.H. Rhee, D. Hwang, Murine TOLL-like receptor4 confers lipopolysaccharide responsiveness as determined by activation of NF-κB and expression of the inducible cyclooxygenase, J. Biol. Chem. 275 (2000) 34035-34040
36. J.H. Paik, J.H. Ju, J.Y. Lee, M.D. Boudreau, D.H. Hwang, Two opposing effects of non-steroidal anti-inflammatory drugs on the expression of the inducible cyclooxygenase. Mediation through different signaling pathways, J. Biol. Chem. 275 (2000) 28173-28179
37. H.E. Xu, M.H. Lambert, V.G. Montana, D.J. Parks, S.G. Blanchard, P.J. Brown, D.D. Sternbach, J.M. Lehmann, G.B. Wisely, T.M. Willson, S.A. Kliewer, M.V. Milburn, Molecular recognition of fatty acids by peroxisome proliferator-activated receptors, Mol. Cell. Biol. 3 (1999) 397-403
38. S.D. Long, P.H. Pekala, Regulation of GLUT4 gene expression by arachidonic acid. Evidence for multiple pathways, one of which requires oxidation to prostaglandin E2, J. Biol. Chem. 271 (1996) 1138-1144
39. P. Tontonoz, L. Nagy, J.G. Alvarez, V.A. Thomazy, R.M. Evans, PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL, Cell 93 (1998) 241-252
40. K. Yu, W. Bayona, C.B. Kallen, H.P. Harding, C.P. Ravera, G. McMahon, M. Brown, M.A. Lazar, Differential activation of peroxisome proliferator-activated receptors by eicosanoids, J. Biol. Chem. 270 (1995) 23975-23983
41. J.M. Lehmann, J.M. Lenhard, B.B. Oliver, G.M. Ringold, S.A. Kliewer, Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs, J. Biol. Chem. 272 (1997) 3406-3410
42. A.C. Nicholson, J. Han, M. Febbraio, R.L. Silverstein, D.P. Hajjar, Role of CD36, the macrophage class B scavenger receptor, in atherosclerosis, Ann. N. Y. Acad. Sci. 947 (2001) 224-228
43. M. Febbraio, D.P. Hajjar, R.L. Silverstein, CD36: A class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, lipid metabolism, J. Clin. Invest. 108 (2001) 785-791
44. A. Pietsch, C. Weber, M. Goretzki, P.C. Weber, R.L. Lorenz, N-3 but not N-6 fatty acids reduce the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells, Cell. Biochem. Funct. 13 (1995) 211-216
45. G. Krey, O. Braissant, F. L'Horset, E. Kalkhoven, M. Perroud, M.G. Parker, W. Wahli, Fatty acids, eicosanoids, hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay, Mol. Endocrinol. 11 (1997) 779-791
46. M. Gottlicher, E. Widmark, Q. Li, J.A. Gustafsson, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, Proc. Natl. Acad. Sci. USA 89 (1992) 4653-4657